RE: Great step31 Aug 2023 10:47
Yorkshirepragma...'which is equivalent to 2.7 times the standard dose of doxorubicin.'
There are a couple of things which also need highlighting...
1. The larger the dose, the bigger the killing power.
2. The bigger the killing power the sooner the tumours are melted away.
3. The sooner you melt away a tumour the less chance the tumour cells have to become dox resistant.
4. As AVA6000 is designed to seek out tumours anywhere in the body due to the FAP content, the more likely Dox will make it to all the tumours regardless of where they might be hiding and regardless of their size.
5. The highly targetted AVA6000 mechanism protects other vital organs such as the heart which in itself is ground breaking and should lead to faster recovery times and far less chance of long term permanent damage.
I apologise for not putting the above point in medical speak but I think we all get the drift.
For anyone on here who hasn't had cancer affect their lives be it directly or indirectly it's very difficult for you to perhaps understand what is involved. From the point of being told you or a loved one has cancer, lives are changed instantly and forever. Even when you're told you are in remission, nothing will ever be the same again. It's still a dark cloud over your head not knowing if it will come back again. The suffering people have to go through both physically and mentally can be horrendous. Yes, many trials fail but without them we will never know if something works or not. Right now 2.7 times the standard dose of doxorubicin is being (or has been) administered to some extremely poorly people who I'm sure are grasping onto every day that might be left to them and 'several patients in cohort 5 and earlier cohorts remain on treatment as their disease has not progressed'...how good is that for them. These patients are well into the latter stages so what might the results be if AVA6000 can be administered much, much earlier.
There's no certs in life but so far AVA6000 does look very promising.
Sign In
Follow the stocks
